AKT1 and cancer: Moreover, luteolin effectively limits the expression levels of many proteins including extracellular signal‐regulated kinase (phosphorylated (p)‐Erk1/2), epidermal growth factor receptors, (p‐EGFR and p‐Akt), and activator of transcription and signal transducer (p‐STAT3) in cancer cells (Imran et al. 2019).